Out of the 33 analysts that have coverage on Zydus Lifesciences, 17 of them have a “buy” rating, 10 say “hold”, while six of them have a “sell” rating on the stock.
Out of the 33 analysts that have coverage on Zydus Lifesciences, 17 of them have a “buy” rating, 10 say “hold”, while six of them have a “sell” rating on the stock.